Suppr超能文献

提高糖尿病视网膜病变筛查参与率的干预措施。

Interventions to increase attendance for diabetic retinopathy screening.

作者信息

Lawrenson John G, Graham-Rowe Ella, Lorencatto Fabiana, Burr Jennifer, Bunce Catey, Francis Jillian J, Aluko Patricia, Rice Stephen, Vale Luke, Peto Tunde, Presseau Justin, Ivers Noah, Grimshaw Jeremy M

机构信息

Centre for Applied Vision Research, School of Health Sciences, City University of London, Northampton Square, London, UK, EC1V 0HB.

出版信息

Cochrane Database Syst Rev. 2018 Jan 15;1(1):CD012054. doi: 10.1002/14651858.CD012054.pub2.

Abstract

BACKGROUND

Despite evidence supporting the effectiveness of diabetic retinopathy screening (DRS) in reducing the risk of sight loss, attendance for screening is consistently below recommended levels.

OBJECTIVES

The primary objective of the review was to assess the effectiveness of quality improvement (QI) interventions that seek to increase attendance for DRS in people with type 1 and type 2 diabetes.Secondary objectives were:To use validated taxonomies of QI intervention strategies and behaviour change techniques (BCTs) to code the description of interventions in the included studies and determine whether interventions that include particular QI strategies or component BCTs are more effective in increasing screening attendance;To explore heterogeneity in effect size within and between studies to identify potential explanatory factors for variability in effect size;To explore differential effects in subgroups to provide information on how equity of screening attendance could be improved;To critically appraise and summarise current evidence on the resource use, costs and cost effectiveness.

SEARCH METHODS

We searched the Cochrane Library, MEDLINE, Embase, PsycINFO, Web of Science, ProQuest Family Health, OpenGrey, the ISRCTN, ClinicalTrials.gov, and the WHO ICTRP to identify randomised controlled trials (RCTs) that were designed to improve attendance for DRS or were evaluating general quality improvement (QI) strategies for diabetes care and reported the effect of the intervention on DRS attendance. We searched the resources on 13 February 2017. We did not use any date or language restrictions in the searches.

SELECTION CRITERIA

We included RCTs that compared any QI intervention to usual care or a more intensive (stepped) intervention versus a less intensive intervention.

DATA COLLECTION AND ANALYSIS

We coded the QI strategy using a modification of the taxonomy developed by Cochrane Effective Practice and Organisation of Care (EPOC) and BCTs using the BCT Taxonomy version 1 (BCTTv1). We used Place of residence, Race/ethnicity/culture/language, Occupation, Gender/sex, Religion, Education, Socioeconomic status, and Social capital (PROGRESS) elements to describe the characteristics of participants in the included studies that could have an impact on equity of access to health services.Two review authors independently extracted data. One review author entered the data into Review Manager 5 and a second review author checked them. Two review authors independently assessed risks of bias in the included studies and extracted data. We rated certainty of evidence using GRADE.

MAIN RESULTS

We included 66 RCTs conducted predominantly (62%) in the USA. Overall we judged the trials to be at low or unclear risk of bias. QI strategies were multifaceted and targeted patients, healthcare professionals or healthcare systems. Fifty-six studies (329,164 participants) compared intervention versus usual care (median duration of follow-up 12 months). Overall, DRS attendance increased by 12% (risk difference (RD) 0.12, 95% confidence interval (CI) 0.10 to 0.14; low-certainty evidence) compared with usual care, with substantial heterogeneity in effect size. Both DRS-targeted (RD 0.17, 95% CI 0.11 to 0.22) and general QI interventions (RD 0.12, 95% CI 0.09 to 0.15) were effective, particularly where baseline DRS attendance was low. All BCT combinations were associated with significant improvements, particularly in those with poor attendance. We found higher effect estimates in subgroup analyses for the BCTs 'goal setting (outcome)' (RD 0.26, 95% CI 0.16 to 0.36) and 'feedback on outcomes of behaviour' (RD 0.22, 95% CI 0.15 to 0.29) in interventions targeting patients, and 'restructuring the social environment' (RD 0.19, 95% CI 0.12 to 0.26) and 'credible source' (RD 0.16, 95% CI 0.08 to 0.24) in interventions targeting healthcare professionals.Ten studies (23,715 participants) compared a more intensive (stepped) intervention versus a less intensive intervention. In these studies DRS attendance increased by 5% (RD 0.05, 95% CI 0.02 to 0.09; moderate-certainty evidence).Fourteen studies reporting any QI intervention compared to usual care included economic outcomes. However, only five of these were full economic evaluations. Overall, we found that there is insufficient evidence to draw robust conclusions about the relative cost effectiveness of the interventions compared to each other or against usual care.With the exception of gender and ethnicity, the characteristics of participants were poorly described in terms of PROGRESS elements. Seventeen studies (25.8%) were conducted in disadvantaged populations. No studies were carried out in low- or middle-income countries.

AUTHORS' CONCLUSIONS: The results of this review provide evidence that QI interventions targeting patients, healthcare professionals or the healthcare system are associated with meaningful improvements in DRS attendance compared to usual care. There was no statistically significant difference between interventions specifically aimed at DRS and those which were part of a general QI strategy for improving diabetes care. This is a significant finding, due to the additional benefits of general QI interventions in terms of improving glycaemic control, vascular risk management and screening for other microvascular complications. It is likely that further (but smaller) improvements in DRS attendance can also be achieved by increasing the intensity of a particular QI component or adding further components.

摘要

背景

尽管有证据支持糖尿病视网膜病变筛查(DRS)在降低失明风险方面的有效性,但筛查的参与率一直低于推荐水平。

目的

本综述的主要目的是评估旨在提高1型和2型糖尿病患者DRS参与率的质量改进(QI)干预措施的有效性。次要目的是:使用经过验证的QI干预策略和行为改变技术(BCTs)分类法,对纳入研究中的干预措施描述进行编码,并确定包含特定QI策略或BCT组成部分的干预措施在提高筛查参与率方面是否更有效;探讨研究内部和研究之间效应大小的异质性,以确定效应大小变异性的潜在解释因素;探讨亚组中的差异效应,以提供关于如何提高筛查参与率公平性的信息;严格评估和总结关于资源使用、成本和成本效益的现有证据。

检索方法

我们检索了Cochrane图书馆、MEDLINE、Embase、PsycINFO、科学引文索引、ProQuest家庭健康数据库、OpenGrey、国际标准随机对照试验编号注册库、ClinicalTrials.gov和世界卫生组织国际临床试验平台,以识别旨在提高DRS参与率或评估糖尿病护理一般质量改进(QI)策略并报告干预措施对DRS参与率影响的随机对照试验(RCTs)。我们于2017年2月13日检索了这些资源。检索过程中未使用任何日期或语言限制。

选择标准

我们纳入了将任何QI干预措施与常规护理进行比较,或将强化(分阶段)干预措施与非强化干预措施进行比较的RCTs。

数据收集与分析

我们使用对Cochrane有效实践与护理组织(EPOC)开发的分类法进行修改后的方法对QI策略进行编码,并使用BCT分类法版本1(BCTTv1)对BCTs进行编码。我们使用居住地、种族/民族/文化/语言、职业、性别/性、宗教、教育、社会经济地位和社会资本(PROGRESS)要素来描述纳入研究中可能影响获得卫生服务公平性的参与者特征。两位综述作者独立提取数据。一位综述作者将数据录入Review Manager 5,另一位综述作者进行核对。两位综述作者独立评估纳入研究中的偏倚风险并提取数据。我们使用GRADE对证据的确定性进行评级。

主要结果

我们纳入了66项RCTs,其中大部分(62%)在美国进行。总体而言,我们判断这些试验的偏倚风险为低或不明确。QI策略是多方面的,针对患者、医疗保健专业人员或医疗保健系统。56项研究(329,164名参与者)比较了干预措施与常规护理(中位随访时间为12个月)。总体而言,与常规护理相比,DRS参与率提高了12%(风险差异(RD)0.12,95%置信区间(CI)0.10至0.1 /span>4;低确定性证据),效应大小存在实质性异质性。针对DRS的干预措施(RD 0.17,95%CI 0.11至0.22)和一般QI干预措施(RD 0.12,95%CI 0.09至0.15)均有效,尤其是在基线DRS参与率较低的情况下。所有BCT组合均与显著改善相关,尤其是在参与率较低的人群中。我们在针对患者的干预措施亚组分析中发现,BCTs“目标设定(结果)”(RD 0.26,95%CI 0.16至0.36)和“行为结果反馈”(RD 0.22,95%CI 0.15至0.29)的效应估计值较高,在针对医疗保健专业人员的干预措施亚组分析中,“社会环境重组”(RD 0.19,95%CI 0.12至0.26)和“可靠来源”(RD 0.16,95%CI 0.08至0.24)的效应估计值较高。10项研究(23,715名参与者)比较了强化(分阶段)干预措施与非强化干预措施。在这些研究中,DRS参与率提高了5%(RD 0.05,95%CI 0.02至0.09;中等确定性证据)。14项报告了与常规护理相比的任何QI干预措施的研究纳入了经济结果。然而,其中只有5项是全面的经济评估。总体而言,我们发现没有足够的证据就干预措施相互之间或与常规护理相比的相对成本效益得出有力结论。除了性别和种族外,参与者的特征在PROGRESS要素方面描述不佳。17项研究(25.8%)在弱势群体中进行。没有在低收入或中等收入国家开展研究。

作者结论

本综述结果提供了证据,表明针对患者、医疗保健专业人员或医疗保健系统的QI干预措施与常规护理相比,在提高DRS参与率方面有显著改善。专门针对DRS的干预措施与作为改善糖尿病护理一般QI策略一部分的干预措施之间没有统计学上的显著差异。这是一个重要发现,因为一般QI干预措施在改善血糖控制、血管风险管理和其他微血管并发症筛查方面还有额外益处。通过增加特定QI组成部分的强度或添加更多组成部分,可能还能进一步(但幅度较小地)提高DRS参与率。

相似文献

1
Interventions to increase attendance for diabetic retinopathy screening.
Cochrane Database Syst Rev. 2018 Jan 15;1(1):CD012054. doi: 10.1002/14651858.CD012054.pub2.
2
Interventions for promoting habitual exercise in people living with and beyond cancer.
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
3
Interventions targeted at women to encourage the uptake of cervical screening.
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
4
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.
Cochrane Database Syst Rev. 2021 Nov 26;11(11):CD013307. doi: 10.1002/14651858.CD013307.pub3.
5
Community screening for visual impairment in older people.
Cochrane Database Syst Rev. 2018 Feb 20;2(2):CD001054. doi: 10.1002/14651858.CD001054.pub3.
6
Strategies to improve smoking cessation rates in primary care.
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD011556. doi: 10.1002/14651858.CD011556.pub2.
7
Interventions for eye movement disorders due to acquired brain injury.
Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD011290. doi: 10.1002/14651858.CD011290.pub2.
8
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Face-to-face interventions for informing or educating parents about early childhood vaccination.
Cochrane Database Syst Rev. 2018 May 8;5(5):CD010038. doi: 10.1002/14651858.CD010038.pub3.
10
Electronic cigarettes for smoking cessation.
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.

引用本文的文献

1
Balancing Efficiency and Equity in Population-Wide CKD Screening.
JAMA Netw Open. 2025 Apr 1;8(4):e254740. doi: 10.1001/jamanetworkopen.2025.4740.
2
Audit and feedback: effects on professional practice.
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD000259. doi: 10.1002/14651858.CD000259.pub4.
6
Advanced Visualization Engineering for Vision Disorders: A Clinically Focused Guide to Current Technology and Future Applications.
Ann Biomed Eng. 2024 Feb;52(2):178-207. doi: 10.1007/s10439-023-03379-8. Epub 2023 Oct 20.
7
EyeArt artificial intelligence analysis of diabetic retinopathy in retinal screening events.
Int Ophthalmol. 2023 Dec;43(12):4851-4859. doi: 10.1007/s10792-023-02887-9. Epub 2023 Oct 17.
8
A cohort follow-up study for diabetic retinopathy screening incidence in the North Denmark Region.
Acta Diabetol. 2023 Nov;60(11):1581-1590. doi: 10.1007/s00592-023-02146-4. Epub 2023 Jul 12.
9
Sociodemographic disparities in ophthalmological clinical trials.
BMJ Open Ophthalmol. 2023 Feb;8(1). doi: 10.1136/bmjophth-2022-001175.

本文引用的文献

1
The impact of a co-payment on the cost-effectiveness of screening for diabetic retinopathy.
J Public Health (Oxf). 2016 Dec 2;38(4):782-792. doi: 10.1093/pubmed/fdv168.
7
Standards of medical care in diabetes-2015 abridged for primary care providers.
Clin Diabetes. 2015 Apr;33(2):97-111. doi: 10.2337/diaclin.33.2.97.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验